Hiroyuki Koide Selected Research

Polo-Like Kinase 1

1/2018

Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Koide Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 01/2008
4	Brain Ischemia (Cerebral Ischemia) 10/2023 - 01/2016
4	Melanoma (Melanoma, Malignant) 01/2015 - 03/2008
3	Reperfusion Injury 10/2023 - 06/2016
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2019 - 01/2016
3	Ischemic Stroke 01/2017 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2012 - 03/2008
2	Infections 10/2023 - 01/2017
2	Triple Negative Breast Neoplasms 01/2023 - 01/2018
2	Hyperglycemia 01/2021 - 01/2019
2	Sepsis (Septicemia) 01/2021 - 12/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 03/2011
2	Ischemia 01/2017 - 02/2009
1	Inflammation (Inflammations) 10/2023
1	Hemolysis 01/2021
1	Amyloidosis 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Cerebral Hemorrhage 01/2017
1	Necrosis 01/2017
1	Stroke (Strokes) 01/2017
1	Thrombosis (Thrombus) 01/2017
1	Cerebral Infarction 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2012
1	Experimental Melanoma 01/2012
1	Fibrosarcoma 03/2011

Drug/Important Bio-Agent (IBA)

10	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2011
5	Triethylenephosphoramide (TEPA)IBA 01/2015 - 01/2011
4	PolymersIBA 01/2023 - 01/2019
4	Liposomes (Liposome)IBA 01/2023 - 03/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2012
3	Peptides (Polypeptides)IBA 01/2023 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 05/2014
3	Neuroprotective AgentsIBA 01/2017 - 01/2016
3	alanyl-prolyl-arginyl-prolyl-glycineIBA 05/2014 - 01/2011
2	Melitten (Melittin)IBA 01/2023 - 01/2021
2	HydrogelsIBA 01/2021 - 10/2019
2	Histones (Histone)IBA 01/2021 - 12/2017
2	fasudil (AT 877)IBA 01/2017 - 06/2016
2	Therapeutic UsesIBA 01/2016 - 05/2014
2	TOR Serine-Threonine KinasesIBA 01/2015 - 01/2011
1	LigandsIBA 10/2023
1	HMGB1 Protein (HMG1)IBA 10/2023
1	CytokinesIBA 10/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	TensinsIBA 01/2023
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	poly-N-isopropylacrylamideIBA 01/2021
1	CarbohydratesIBA 01/2021
1	ClathrinIBA 07/2020
1	patisiranIBA 01/2020
1	Prealbumin (Transthyretin)IBA 01/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2019
1	ifenprodilIBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019
1	Indicators and Reagents (Reagents)IBA 10/2019
1	diethylenetriamineIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	MorpholinosIBA 01/2019
1	DEET (DET)IBA 01/2019
1	dioleoyl phosphateIBA 01/2019
1	indoleIBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Polo-Like Kinase 1IBA 01/2018
1	Radioisotopes (Radionuclides)IBA 01/2018
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2018
1	Lipid NanoparticlesIBA 01/2018
1	N-isopropylacrylamideIBA 12/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	InterferonsIBA 01/2017
1	rho-Associated KinasesIBA 06/2016
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2016
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2015
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2014
1	NaphthoquinonesIBA 01/2012
1	arginyl-glycyl-aspartic acidIBA 01/2012
1	EstersIBA 01/2012
1	rhinacanthin-NIBA 01/2012
1	CholesterolIBA 03/2011
1	LuciferasesIBA 03/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2011
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2011
1	Oxygen (Dioxygen)IBA 02/2009
1	gamma-sitosterol (beta-sitosterol)IBA 03/2008
1	Phosphatidylcholines (Phosphatidylcholine)IBA 03/2008
1	PicibanilIBA 01/2008

Therapy/Procedure

8	Therapeutics 10/2023 - 01/2011
6	Intravenous Injections 01/2023 - 05/2014
1	Thrombolytic Therapy 01/2017
1	Intravenous Administration 06/2016
1	Drug Therapy (Chemotherapy) 01/2012
1	Chemoprevention 03/2008